TAKEDA PHARMACEUTICAL CO LTD

13F Portfolio Filings

  • Most recent 13F
    Q4 2024
  • Location
    tokyo, M0
  • CIK
    0001395064
  • All SEC filings
Q4 2024
Quater
Holdings
VALUE
Top Holdings
Form Type
Date Filed
Filing Id

11

$26.57M
HLVX, OVID, XLO, EQ
13F-HR
Feb 12, 2025
000139506425000019

10

$37.95M
HLVX, WAVE LIFE SCIENCES LTD, OVID, STTK
13F-HR
Feb 13, 2025
000139506425000030

13

$232.31M
DNLI, HLVX, PHAT, WAVE LIFE SCIENCES LTD
13F-HR
Feb 13, 2025
000139506425000028

15

$289.04M
HLVX, DNLI, PHAT, OVID
13F-HR
Feb 13, 2025
000139506425000026

14

$327.50M
HLVX, DNLI, PHAT, OVID
13F-HR
Feb 13, 2025
000139506425000024
Takeda Pharmaceutical Co Ltd 13F Filings